Author:
Tian Mei,Zuo Chuantao,Civelek Ali Cahid,Carrio Ignasi,Watanabe Yasuyoshi,Kang Keon Wook,Murakami Koji,Garibotto Valentina,Prior John O.,Barthel Henryk,Guan Yihui,Lu Jiaying,Zhou Rui,Jin Chentao,Wu Shuang,Zhang Xiaohui,Zhong Yan,Zhang Hong,
Abstract
AbstractAlzheimer’s disease (AD) is the main cause of dementia, with its diagnosis and management remaining challenging. Amyloid positron emission tomography (PET) has become increasingly important in medical practice for patients with AD. To integrate and update previous guidelines in the field, a task group of experts of several disciplines from multiple countries was assembled, and they revised and approved the content related to the application of amyloid PET in the medical settings of cognitively impaired individuals, focusing on clinical scenarios, patient preparation, administered activities, as well as image acquisition, processing, interpretation and reporting. In addition, expert opinions, practices, and protocols of prominent research institutions performing research on amyloid PET of dementia are integrated. With the increasing availability of amyloid PET imaging, a complete and standard pipeline for the entire examination process is essential for clinical practice. This international consensus and practice guideline will help to promote proper clinical use of amyloid PET imaging in patients with AD.
Funder
National Natural Science Foundation of China
Clinical Research Plan of SHDC
Science and Technology Innovation 2030 Major Projects
Publisher
Springer Science and Business Media LLC
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献